TrialThe oncologist2020

Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.

Gabriele Reinartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.